- Filed
- May 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2026 · Jan 31, 2025 | $208.5M |
| Cash And Equivalents | Q1 2026 · Apr 30, 2024 | $225.37M |
| Stockholders Equity | Q1 2026 · Jan 31, 2025 | $481.33M |
| Stockholders Equity restated | Q1 2026 · Apr 30, 2024 | $489.6M |
| Current Liabilities | Q1 2026 · Jan 31, 2025 | $112.96M |
| Current Liabilities restated | Q1 2026 · Apr 30, 2024 | $103.37M |
| Total Liabilities | Q1 2026 · Jan 31, 2025 | $245.65M |
| Total Liabilities restated | Q1 2026 · Apr 30, 2024 | $244.14M |
| Current Assets | Q1 2026 · Jan 31, 2025 | $489.94M |
| Current Assets restated | Q1 2026 · Apr 30, 2024 | $501.89M |
| Total Assets | Q1 2026 · Jan 31, 2025 | $729.23M |
| Total Assets restated | Q1 2026 · Apr 30, 2024 | $736M |
| Shares Diluted | Q1 2026 · Apr 30, 2024 | 22.67M sh |
| Stock Repurchased | Q1 2026 · Apr 30, 2024 | $1.09M |
| Dividends Paid | Q1 2026 · Apr 30, 2024 | $7.77M |
| Capex | Q1 2026 · Apr 30, 2024 | $1.62M |
| Operating Cash Flow | Q1 2026 · Apr 30, 2024 | −$18.07M |
| Eps Diluted restated | Q1 2026 · Apr 30, 2024 | $0.09 |
| Eps Basic restated | Q1 2026 · Apr 30, 2024 | $0.09 |
| Sga Expense restated | Q1 2026 · Apr 30, 2024 | $70.8M |
| Net Income restated | Q1 2026 · Apr 30, 2024 | $2.02M |
| Operating Income restated | Q1 2026 · Apr 30, 2024 | $2.12M |
| Gross Profit restated | Q1 2026 · Apr 30, 2024 | $72.92M |
| Cost Of Revenue restated | Q1 2026 · Apr 30, 2024 | $61.46M |
| Revenue restated | Q1 2026 · Apr 30, 2024 | $134.38M |